GlassScriptPhysician profile
John Joseph Vargo
NPI 1316930100
$2,491.91
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
See the full distribution for Geriatric Medicine (Family Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $1,366 · 2021: $438.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $473.17 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $217.95 | 2019-2021 | |
| Cook Medical LLC | $209.16 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $204.14 | 2019-2021 | |
| Amarin Pharma, INC. | $181.36 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $157.64 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $115.17 | 2019-2021 | |
| Glaxosmithkline, LLC. | $92.06 | 2020-2021 | |
| Novo Nordisk INC | $84.75 | 2019-2021 | |
| Eisai INC. | $84.33 | 2020-2021 | |
| Steris Corporation | $81.67 | 2021 | |
| Allergan, INC. | $77.83 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $77.52 | 2020-2021 | |
| Indivior INC. | $71.96 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $68.25 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $68.15 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $53.82 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $39.48 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $22.97 | 2019-2020 | |
| Daiichi Sankyo INC. | $22.58 | 2020 | |
| Redhill Biopharma INC. | $19.71 | 2020 | |
| Otsuka America Pharmaceutical, INC. | $16.49 | 2020 | |
| Ironwood Pharmaceuticals, INC | $14.13 | 2020 | |
| Sanofi-Aventis U.S. LLC | $13.71 | 2019 | |
| Astellas Pharma US INC | $12.85 | 2021 | |
| Horizon Therapeutics Plc | $11.06 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Vargo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.